CORT Q3 2022 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$102M+5.8% YoY

Gross Profit

$100M98.7% margin

Operating Income

$32M31.4% margin

Net Income

$35M34.0% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$33M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$533M

Total Liabilities

$60M

Stockholders' Equity

$473M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$96M	+5.8%
Gross Profit	$100M	$95M	+5.8%
Operating Income	$32M	$36M	-11.9%
Net Income	$35M	$30M	+13.6%